
Maleexcel
MaleExcel is a tele-medicine brand that prescribes and ships FDA-approved men’s health medications: testosterone replacement, erectile-dysfunction tablets, daily Cialis, HCG, and ancillary supplies. All care is delivered online through a subscription model; first consult is $99, ongoing meds start around $79/month, placing the offer in the mid-range between cheap generics and high-touch urology clinics. Products are fulfilled by partner compounding pharmacies and mailed in discreet packaging; there is no retail storefront.
The company differentiates by bundling licensed U.S. medical care with medication: patients complete an online intake, upload labs, then consult a physician every 90 days without leaving home. Same-day prescribing and free 2-day shipping create a “click-to-cure” loop that replaces the traditional doctor-pharmacy run. MaleExcel’s 200 mg/mL bioidentical testosterone cypionate and compounded sublingual sildenafil are its most prescribed SKUs, supported by a mobile portal that tracks dosage, follow-ups, and refill dates.
Core customer is 30-55-year-old U.S. men experiencing low-T or ED symptoms who value privacy, speed, and continuity of care over bargain hunting. They are typically employed, time-pressed, comfortable with subscription services, and motivated by performance, physique, and energy rather than cosmetic youth. The brand voice is data-driven and clinical, appealing to guys who want medical legitimacy without the stigma of in-person visits.
MaleExcel competes with three tiers: big-box retail pharmacies selling cash-pay generics, venture-funded men’s tele-health platforms, and anti-aging clinics offering cash-only hormone programs. It separates itself by requiring real lab work and ongoing physician oversight instead of questionnaire-only prescribing, while still undercutting boutique clinic pricing and offering pharmacy-direct fulfillment that retail chains cannot match for convenience.
Real doctor, real results, your privacy preserved
Visit site
Fellahealth
Fella Health sells physician-supervised weight-loss programs built around GLP-1 medications (compounded semaglutide and tirzepatide), at-home metabolic lab kits, and ongoing telehealth coaching. Packages are priced at a mid-range level—typically $200-$400 per month including medication, consultations, and digital support—and are available only through the brand’s online platform; no retail or pharmacy pickup is required.
The company differentiates itself by focusing exclusively on men with a BMI ≥30, pairing prescription medication with testosterone optimization and strength-centric lifestyle plans. All treatment plans are written by U.S.-licensed physicians, shipped in discreet packaging, and supported by a mobile app that tracks biomarkers, nutrition, and workout data, creating a data-driven, masculine frame around medical weight loss.
Core customers are 25-55-year-old men who have plateaued with diet and exercise alone, value privacy, and prefer a tech-enabled, pharma-grade solution over in-person clinics. The brand speaks to performance, convenience, and scientific credibility, appealing to guys who want to lose visceral fat while preserving muscle and avoiding “diet-culture” messaging.
Fella competes with national telehealth weight-loss platforms and men’s wellness clinics that prescribe GLP-1 drugs. It separates itself by narrowing the audience to men, bundling testosterone screening, emphasizing strength outcomes rather than scale weight, and pricing below traditional concierge medical practices while offering faster onboarding than hospital-based programs.
Lose fat, keep muscle, skip the clinic visits entirely
Visit site
MyDietDoc
MyDietDoc sells physician-supervised weight-loss programs delivered 100 % online. Core offerings include compounded GLP-1 medications (semaglutide and tirzepatide), metabolic testing kits, and monthly telehealth coaching subscriptions; prices sit in the mid-to-premium tier, typically $250-$450 per month before insurance.
The brand differentiates by pairing every patient with a U.S.-licensed clinician who prescribes and titrates medication without requiring in-person visits, then ships medication from an affiliated compounding pharmacy within 3-5 days. All plans include unlimited messaging, nutrition tracking, and dose adjustments, positioning MyDietDoc as a turnkey medical pathway rather than a supplement or diet plan.
Primary buyers are busy professionals aged 25-55 with 30+ lbs to lose who want clinically proven results but lack time for brick-and-mortar clinics; they value privacy, speed, and medical oversight over flashy lifestyle branding. Messaging emphasizes science, safety, and sustainable weekly fat loss rather than cosmetic quick fixes.
MyDietDoc competes with telehealth GLP-1 startups, cash-pay medical weight-loss chains, and direct-to-consumer supplement brands. It separates itself by bundling prescription authority, personalized titration, and ongoing physician access into one flat monthly fee, avoiding the upsell tiers common among competitors while remaining fully virtual.
Your doctor adjusts your medication while you live your life
Visit site
Shedrx
Shedrx is a direct-to-consumer telehealth brand that prescribes and ships GLP-1 receptor-agonist weight-loss medications (semaglutide and tirzepatide) and complementary metabolic-support supplements. All care is handled online through a virtual consultation, prescription, and monthly subscription that lands between mid-range and premium pricing—typically $299-$399 for a 4-week compounded injectable supply. The company operates exclusively online; no physical pharmacies or clinics are involved.
The brand’s core edge is speed-to-treatment: most patients complete intake, provider review, and pharmacy dispatch within 48 hours, with medication arriving cold-shipped to their door. Shedrx formulates its own compounded versions of the active ingredients, allowing it to stay in stock during national shortages and to offer dose-titration packs that larger drug-makers do not. A mobile dashboard tracks dosage, side-effects, and progress, reinforcing adherence and data-driven adjustments.
The typical buyer is a 30-55-year-old U.S. resident with a BMI ≥27 who wants physician-guided weight loss without insurance hurdles or in-person visits. Convenience, discretion, and a “life-hack” mindset drive the purchase; customers value being able to start therapy quickly while still under clinician oversight rather than relying on lifestyle apps alone.
Shedrx competes in the fast-growing tele-weight-loss segment populated by digital clinics and wellness subscription services. It differentiates through guaranteed compounded-drug availability, transparent flat pricing, and integrated progress tracking, positioning itself as a faster, more reliable alternative to both traditional insurance-based programs and generic online pharmacies.
Weight loss that actually ships faster than your excuses
Visit site
Joinweightcare
Joinweightcare is a direct-to-consumer, online-only wellness platform that bundles prescription GLP-1 weight-loss medications (compounded semaglutide and tirzepatide) with telehealth consults, at-home lab kits, and digital coaching. Medication plans start around $199 for the first month and move to $299–$399 per month thereafter, placing the brand in the mid-range tier below big-pharma list prices but above discount peptide sites. All orders are fulfilled by partner compounding pharmacies and shipped to 40+ U.S. states after an asynchronous doctor approval.
The company’s core promise is “prescription + support in one click”: patients complete a 5-minute intake, receive same-day provider review, and get ongoing dose adjustments without leaving the app. Every subscription includes unlimited messaging with the prescribing clinician, a smart-scale integration, and a calorie-tracking app at no extra cost. This bundled model has produced a 4.8/5 Trustpilot rating and a cohort where 78 % of members report ≥10 % body-weight reduction within six months.
Typical buyers are 30-55-year-old professionals—predominantly women—who have BMI ≥27 and have cycled through commercial diets without lasting results. They value medical legitimacy, privacy (no in-person visits), and predictable cash pricing that avoids insurance denials. The brand speaks in clinical but encouraging tones, emphasizing metabolic health over vanity metrics.
Joinweightcare competes with telehealth pill-and-shot startups, cash-pay med-spas, and traditional weight-loss programs. It differentiates by combining compounded GLP-1 access with continuous clinician oversight and behavioral tools under one flat monthly fee, eliminating the need for separate pharmacy, coaching, and lab invoices.
Your doctor, your medication, your coach, all month long
Visit site
Evelyn Health
Evelyn Health sells direct-to-consumer prescription dermatology and hair-loss therapies that are compounded in partner pharmacies and shipped monthly. Core lines include topical and oral formulations of finasteride, minoxidil, tretinoin, clindamycin and spironolactone, priced at mid-range subscription tiers of US $30-60 per month. All consultations, billing and fulfillment are handled through the brand’s own telehealth platform; no physical retail is offered.
The company differentiates by bundling asynchronous doctor consults, unlimited provider messaging and automatic refill synchronization into the subscription price. Every treatment plan is customized from 30-plus ingredient strengths, and progress photos are reviewed mid-cycle with free dosage tweaks. Its best-known bundle is the two-step “Hair Revival” set, advertised to show visible regrowth within 90 days under medical supervision.
Primary customers are 20-45-year-old North American adults experiencing early-stage acne, hair thinning or anti-aging concerns who value discretion and time savings over in-office visits. The brand appeals to data-driven, app-native users who track biometrics, prefer transparent ingredient lists and want ongoing clinician access without insurance hurdles.
Evelyn Health competes with telehealth platforms that repackage generic medications as well as with premium cosmetic brands selling non-prescription serums. It undercuts specialist co-pays by folding consultation fees into product price and outperforms OTC cosmetics by offering FDA-approved active pharmaceuticals in strength combinations unavailable off the shelf.
Doctor-guided treatments customized for your skin, shipped monthly on your schedule
Visit site
Trimrx
Trimrx is an online-only direct-to-consumer brand that sells compounded GLP-1 weight-loss injections—primarily semaglutide and tirzepatide—along with telehealth consultations, starter supply kits, and monthly refill plans. All medications are prescribed and fulfilled through the company’s U.S.-partnered pharmacies; no insurance is required. Pricing sits in the mid-range tier: starter programs open at roughly $299 and monthly refills run $399–$499, placing the brand below most in-clinic peptide clinics but above budget pill-based alternatives.
The company’s core promise is “prescription GLP-1 in 48 hours”: patients complete an asynchronous intake, a state-licensed clinician reviews within one business day, and medication ships overnight from an affiliated pharmacy. Doses are customized to the nearest 0.1 mg, vials arrive in temperature-controlled packaging with pre-loaded syringes, and unlimited dosage adjustments are included. Trimrx markets itself as the fastest, most transparent tele-GLP-1 option, publishing real-time pharmacy inventory and batch-level Certificates of Analysis online.
Trimrx targets busy professionals aged 25-55 who want clinically proven weight-loss injectables without clinic visits, insurance hurdles, or brand-name mark-ups. Customers value speed, privacy, and data—many track body-composition metrics and share progress in the brand’s private Slack community. The aesthetic is clean, medical-minimalist, appealing to consumers who already subscribe to DTC services for hair, skin, or hormone care.
Competitors include other telehealth platforms offering compounded semaglutide, cash-pay medical spas, and traditional pharmacies. Trimrx differentiates through faster fulfillment (48-hour average), flat monthly pricing that covers all clinician touchpoints, and public lot-level testing—practices not universally offered by rival tele-GPL-1 sites.
GLP-1 in 48 hours, transparent dosing, no clinic visits required
Visit site